Up to 85 percent of all lung cancer cases are characterized as non-small cell lung cancer, underscoring the importance of keeping up to date on the latest diagnostic and treatment advances. That’s why this Spotlight on Non-Small Cell Lung Cancer brings together leading oncologists and other allied healthcare professionals to discuss key research updates and other novel insights.
Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
Vivek Subbiah, MDPeer
Recognizing the Role of Capmatinib for METex14 in NSCLC